Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study

Introduction: Immune checkpoint inhibitor (ICI) therapy is markedly improving the prognosis of patients with several types of cancer. On the other hand, the growth in the use of these drugs in oncology is associated with an increase in multiple immune-related adverse events (irAEs), whose optimal pr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Iñigo Les, Inés Pérez-Francisco, María Cabero, Cristina Sánchez, María Hidalgo, Lucía Teijeira, Virginia Arrazubi, Severina Domínguez, Pilar Anaut, Saioa Eguiluz, Iñaki Elejalde, Alberto Herrera, Mireia Martínez
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-06-01
Colecção:	Frontiers in Pharmacology
Assuntos:	immune checkpoint inhibitors immune-related adverse events cancer autoantibodies prospective cohort study multicenter
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2022.894550/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!